Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration SRAS - Exploration (Accueil)

Index « Keywords » - entrée « Antiviral Agents (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiviral Agents (pharmacokinetics) < Antiviral Agents (pharmacology) < Antiviral Agents (physiology)  Facettes :

List of bibliographic references indexed by Antiviral Agents (pharmacology)

Number of relevant bibliographic references: 330.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000104 (2020) Sean Ekins [États-Unis] ; Thomas R. Lane [États-Unis] ; Peter B. Madrid [États-Unis]Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.
000108 (2020) David CyranoskiThis scientist hopes to test coronavirus drugs on animals in locked-down Wuhan.
000109 (2020) Inder P. Singh [Inde] ; Shiv Gupta [Inde] ; Sanjay Kumar [Inde]Thiazole Compounds as Antiviral Agents: An Update.
000147 (2020) Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada]The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
000316 (2020) Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine]Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
000356 (2020) Emmie De Wit ; Friederike Feldmann ; Jacqueline Cronin ; Robert Jordan ; Atsushi Okumura ; Tina Thomas ; Dana Scott ; Tomas Cihlar ; Heinz FeldmannProphylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
000463 (2020) Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie]Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
000560 (2020) Claudia Cava [Italie] ; Gloria Bertoli [Italie] ; Isabella Castiglioni [Italie]In Silico Discovery of Candidate Drugs against Covid-19.
000579 (2020) Young Sup Shin [Corée du Sud] ; Dnyandev B. Jarhad [Corée du Sud] ; Min Hwan Jang [Corée du Sud] ; Kristina Kovacikova [Pays-Bas] ; Gyudong Kim [Corée du Sud] ; Ji-Seong Yoon [Corée du Sud] ; Hong-Rae Kim [Corée du Sud] ; Young Eum Hyun [Corée du Sud] ; Amol S. Tipnis [Corée du Sud] ; Tong-Shin Chang [Corée du Sud] ; Martijn J. Van Hemert [Pays-Bas] ; Lak Shin Jeong [Corée du Sud]Identification of 6'-β-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication.
000720 (2020) Han Ju [République populaire de Chine] ; Siyu Xiu [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Min Shang [République populaire de Chine] ; Ruifang Jia [République populaire de Chine] ; Bing Huang [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine]Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
000722 (2020) Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine]Discovering drugs to treat coronavirus disease 2019 (COVID-19).
000987 (2020) Catherine S. Adamson [Royaume-Uni]Antiviral Agents: Discovery to Resistance.
000B00 (2019) Zheng Li ; Jing-Ya Ruan ; Fan Sun ; Jie-Jing Yan ; Jian-Li Wang ; Zi-Xin Zhang ; Yi Zhang ; Tao WangRelationship between Structural Characteristics and Plant Sources along with Pharmacology Research of Quassinoids.
000B07 (2019) Andrea J. Pruijssers [États-Unis] ; Mark R. Denison [États-Unis]Nucleoside analogues for the treatment of coronavirus infections
000B18 (2019) Seri Jo ; Suwon Kim ; Dong Hae Shin ; Mi-Sun KimInhibition of SARS-CoV 3CL protease by flavonoids
000B45 (2019) Kouji Ohnishi [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenichi Akaji [Japon]Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor.
000B70 (2019) Ren-Jun Wu [République populaire de Chine] ; Kai-Xuan Zhou [République populaire de Chine] ; Haijin Yang [République populaire de Chine] ; Guo-Qing Song [République populaire de Chine] ; Yong-Hong Li [République populaire de Chine] ; Jia-Xin Fu [République populaire de Chine] ; Xiao Zhang [République populaire de Chine] ; Shu-Jing Yu [République populaire de Chine] ; Li-Zhong Wang [République populaire de Chine] ; Li-Xia Xiong [République populaire de Chine] ; Cong-Wei Niu [République populaire de Chine] ; Fu-Hang Song [République populaire de Chine] ; Haitao Yang [République populaire de Chine] ; Jian-Guo Wang [République populaire de Chine]Chemical synthesis, crystal structure, versatile evaluation of their biological activities and molecular simulations of novel pyrithiobac derivatives.
000B74 (2019) Allison L. Totura ; Sina BavariBroad-spectrum coronavirus antiviral drug discovery
000C05 (2018) Julia Sommer [Autriche] ; Susanne Fister [Autriche] ; Tobias Gundolf [Autriche] ; Birgit Bromberger [Autriche] ; Patrick-Julian Mester [Autriche] ; Anna Kristina Witte [Autriche] ; Roland Kalb [Autriche] ; Peter Rossmanith [Autriche]Virucidal or Not Virucidal? That Is the Question-Predictability of Ionic Liquid's Virucidal Potential in Biological Test Systems.
000C14 (2018) M. Giulietti [Italie] ; A. Righetti [Italie] ; L. Cianfruglia [Italie] ; B. Šabanovi [Italie] ; T. Armeni [Italie] ; G. Principato [Italie] ; F. Piva [Italie]To accelerate the Zika beat: Candidate design for RNA interference-based therapy.
000C51 (2018) Hsu-Feng Chu [Taïwan] ; Chiao-Che Chen [Taïwan] ; David C. Moses [Taïwan] ; Yau-Hung Chen [Taïwan] ; Chao-Hsiung Lin [Taïwan] ; Ying-Chieh Tsai [Taïwan] ; Chi-Yuan Chou [Taïwan]Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiviral Agents (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiviral Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiviral Agents (pharmacology)
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021